MOLECULAR CELLULAR BIOLOGY, June 1991, p. 3009-3019                                                                  Vol. 11,  6
0270-7306/91/063009-11$02.00/0
Copyright © 1991, American Society Microbiology


   SPT5, Essential Gene Important Normal Transcription  Saccharomyces cerevisiae, Encodes Acidic Nuclear Protein                     Carboxy-Terminal Repeat
                       MICHELE S. SWANSON, ELIZABETH  MALONE, FRED WINSTON*
                        Department Genetics, Harvard Medical School, Boston, Massachusetts 02115
                                          Received 28 January 1991/Accepted 13 March 1991

              Mutations SPTS gene Saccharomyces cerevisiae isolated previously suppressors 8 insertion
           mutations HIS4 LYS2. study shown sptS mutations suppress his4-9128            lys2-1288 alleles altering transcription. cloned SPTS gene increase            decrease copy number wild-type SPTS gene caused Spt- phenotype. Construction analysis
           sptS null mutation demonstrated SPT5 essential growth, suggesting SPT5 required
           normal transcription large number genes. SPT5 DNA sequence determined; predicted            116-kDa protein extremely acidic amino terminus novel amino-acid repeat carboxy
           terminus (consensus = S-T W-G-G Q). indirect immunofluorescence microscopy showed            bifunctional SPT5-0-galactosidase protein located yeast nucleus. molecular analysis            SPT5 gene revealed number interesting similarities previously characterized SPT6 gene S.
           cerevisiae. results suggest SPT5 SPT6 act related fashion influence essential
           transcriptional processes S. cerevisiae.

   large number mutations alter transcription          gene suppress 8 insertion mutations altering transcrip-
yeast Saccharomyces cerevisiae isolated selection               tion. cloned SPT5 gene used cloned gene suppressors Ty solo 8 insertion mutations HIS4             additional molecular genetic studies SPT5. nu- L YS2 (19, 64, 65). mutations identified 16              cleotide sequence SPT5 gene predicts 1,063-amino-
unlinked genes, named SPT genes  suppressor Ty).                 acid protein highly acidic amino terminus 15
Molecular analysis revealed SPT genes             copies amino-acid repeat carboxy terminus.
encode proteins believed play central roles              Analysis SPT5 repeat domain indicated gene expression: SPT15 encodes TATA-binding protein                 region required SPT5 function. Like SPT6, SPT5 TFIID (16), SPTJJ SPT12 genes               essential growth, proper SPT5 gene dosage critical HTA1 HTBJ, encode histone proteins H2A                    function, SPT5 protein appears located H2B, respectively (12). Genetic analysis remain-             yeast nucleus. molecular analysis supports idea ing spt mutants allowed classification SPT               SPT5 SPT6 functionally related required genes groups, based distinct mutant pheno-                normal transcription S. cerevisiae.
types: group includes SPTJJ SPT12, second
includes SPT15, includes SPT131GALII (19,
20).                                                                                  MATERIALS METHODS
   SPT5 gene, characterized study, SPT6
gene, analyzed previously (13, 45, 61), belong pheno-               Strains genetic methods. S. cerevisiae strains used
typic class represented histone genes HTAJISPTJJ                 studies (Table 1) constructed laboratory HTBJISPTJ2 (12, 19). Mutations genes               derivatives strain S288C (MATot gal2) suppress set Ty 8 insertion mutations            strains YPH149 (24), SF402-4D (Yeast Genetic Stock Cen-
HIS4 L YS2 genes (19, 64) cis-                  ter, Berkeley, Calif.), K396-11A K396-22B (36).
trans-acting mutations severely reduce expression              Parentheses indicate autonomous plasmids, brackets indi- SUC2 gene Ty elements (11, 26, 45, 46, 62).                  cate integrated plasmids, double brackets indicate au-
Previous studies demonstrated altered dosage               tonomous linear chromosomal fragments. Standard methods SPT6 gene HTAJ-HTBJ locus causes similar                     mating, sporulation, tetrad analysis used (43,
mutant phenotypes (12, 13, 45). Molecular analysis demon-               56). lys2-1288 allele consists solo 8 element inserted
strated SPT6 encodes essential nuclear protein 170           153 bp downstream LYS2 translation initiation codon
kDa extremely acidic amino terminus (13, 45, 61).               (13, 59). his4-9128 allele insertion solo 8 studies suggested SPT6 plays essential role            element bp -97 relative HIS4 transcription initiation
transcription, affecting chromatin structure.                site (8, 18). Strains MS194 MS195 contain SPT5-lacZ
  basis observation spt5 mutants                 hybrid genes integrated spt5A202::LEU2 allele. phenotypically similar spt6 histone mutants,                  strains constructed transforming diploid strain
decided analyze SPT5 gene product.               BM80 pMS50 DNA (MS194) pBM68 DNA (MS195)
study, demonstrated mutations SPT5                  linearized restriction digestion PstI.
                                                                        site integration determined sporulating trans-
                                                                        formants, dissecting tetrads, scoring Ura Leu
                                                                        phenotypes spore clones.
  *
      Corresponding author.                                                Media. Rich medium (YPD), minimal medium (SD), sup-
                                                                 3009
 3010       SWANSON ET AL.                                                                                                         MOL. CELL. BIOL.

                                                                   TABLE 1. Yeast strains
 Strain                                                                                            Genotype
FY98 .....................................                 MATa ura3-52 leu2AJ
FY360 .............             ........................   MATa spt5-194 Ieu2AJ
FY382 .............             ........................   MATa sptS-8 ura3-52 leu2AJ
FY120 .............             ........................   MATa his4-9128 Iys2-1288 ura3-52 Ieu2Al
FY300 ............              ........................   MATa sptS-194 ura3-52 his4-9128 Iys2-1288 leu2AJ
FY276 ............              ........................   MATa sptS-8 his4-9128 Iys2-1288 ura3-52 leu2Al
MSll ...........              .........................    MATot sptS-8 lys2-1288 ura3-52 his4-917 Ieu2
MS63 ...........              .........................    MATa spt5-24 his4-9128 lys2-1288 ura3-52 ade2-1 trp5 can1-100
FW1237 .....................................               MATa his4-9128 lys2-1288 ura3-52
MS98 ...........              .........................    MATa his4-9128 lys2-1288 ura3-52 [SPT5-pMS15-URA3]
MS17 ...........              .........................    MATa spt5-24 his4-9128 lys2-1288 ura3-52 ade2-1 canl-100
FY298 ............              ........................   MATa spt5-194 his4-9128 lys2-1288 ura3-52 Ieu2Al ade8
BM60 ...........              .........................    MA Ta/MA Ta ura3-521ura3-52 his4-91281his4-9128 Iys2-128811ys2-1288 leu2-3,1121leu2-3,112
                                                            trplAlltrplAl
BM80 .....................................                 MATa/MATTa spt5A202::LEU21SPT5 ura3-521ura3-52 his4-91281his4-9128 lys2-12881lys2-
                                                            1288 leu2-3,1121leu2-3,112 trplAJ/trpJAl
MS189 .....................................                MATa ura3-52 his4-9128 lys2-1288 leu2Al (pCGS42)
MS190 ....................................                 MATa ura3-52 his4-9128 lys2-1288 leu2AJ (pMS4)
MSl91 ....................................                 MATa ura3-52 his4-9128 lys2-1288 leu2AJ (pMS24)
YPH149 ....................................                MATa ade his7 Iys2 trpJAl ura3-52 [[CFIURA31RAD2 distal]] [[CFITRPJIRAD2
                                                             proximal]]
K396-11A ....................................              MATa Iys7 spoil ura3 adel  Ieu2 met3 trp5
K396-22B ....................................              MATot Iys7 spoll ura3 adel  Ieu2 met3 trpS
SF402-4D .....................................             MATa sec59
MS113.MATa                                                        sptS-24 sec59
  M 13.......................................................MA ast24            his4-9128 lys2-I288 trpJAJl
                                                                           ec9h4918l218               rpA
MS192 ....................................                 MATa lys7 his4-9128 ura3-52
MS193 ....................................                 MAToa Iys7 his4-9128 ura3-52 adel
MS194 .............            ........................ MA Ta/MA [spt5A202: :LEU2-SPT5(917)-lacZ-URA3]ISPT5 ura3-521ura3-52 his4-91281
                                                             his4-9128 lys2-12881lys2-1288 Ieu2A1/Ieu2AJ trpJAJItrplAJ
MS195 .....................................                MATa/MATot [spt5A202::LEU2-SPT5(1004)-lacZ-URA3]/SPT5 ura3-521ura3-52 his4-91281
                                                             his4-9128 lys2-12881lys2-1288 Ieu2A1JIeu2Al trplAlltrplAl
BM418 .....................................                MAToa spt5-194 his4-9128 lys2-1288 ura3-52 ade8
BM437 .....................................                MATot spt5-194 his4-9128 lys2-1288 ade8 [ura3-52-SPT5(1004)-1acZ-URA3]
BM443 ....................................                 MATa his4-9128 Iys2-1288 Ieu2Al [ura3-52-SPT5(1004)-lacZ-URA3]
BM444 ....................................                 MAToa his4-9128 Iys2-1288 Ieu2AI ade8 [ura3-52-SPT5(1004)-lacZ-URA3]
BM448 ....................................                 MATa/MATTa his4-91281his4-9128 lys2-128811ys2-1288 Ieu2Al1Ieu2Al ade8/ADE8 [ura3-52-
                                                             SPT5(1004)-lacZ-URA3]1[ura3-52-SPT5(1004)-lacZ-URA3]
BM454 ....................................                 MATa/MATa his4-91281his4-9128 Iys2-12881/ys2-1288 Ieu2AI/Ieu2AJ ade8/ADE8 [ura3-52-
                                                            SPT5(1004)-lacZ-URA3]1[ura3-52-SPT5(1004)-lacZ-URA3]
BM455 ....................................                 MATTa/MATTa his4-91281his4-9128 Iys2-128811ys2-1288 Ieu2Al1Ieu2AI ade8/ADE8 [ura3-52-
                                                            SPT5(1004)-lacZ-URA3]1[ura3-52-SPT5(1004)-lacZ-URA3]
BM467 .....................................                BM454 x BM455
BM330 .....................................                MATa/MATTa his4-91281his4-9128 Iys2-128811ys2-1288 ura3-521ura3-52 trplA631trplA63
BM331 .....................................                MA Ta/MA Ta his4-91281his4-9128 lys2-12881Iys2-1288 ura3-521ura3-52 trpIA631trplA63
BM339 ....................................                 BM331 x BM330


plemented SD (SD amino acids added                             Seakem agarose (FMC Bioproducts, Rockland, Maine) liquid stock solutions), synthetic complete medium lacking                      purified electroelution, using device designed Larry
single amino acid, sporulation medium prepared                        Peck (49). Southern blot hybridization analysis 
described previously Sherman et al. (56). GNA presporu-                        formed described previously (51). Radiolabeled DNA
lation medium contained 10 g yeast extract, 30 g                            probes prepared nick translation (50) random
nutrient broth, 50 g dextrose, 20 g agar liter.                     priming (21, 22), using  32P]dATP (Amersham) reagent
  Transformations. Yeast cells transformed                            kits Boehringer Mannheim.
lithium acetate method (32). Escherichia coli HB101 (3)                          RNA preparation analysis. Yeast RNA prepared
TB1 (Bethesda Research Laboratories, Gaithersburg, Md.)                           described previously (7) cells grown supple- transformed described previously (41).                                    mented SD medium 25°C density 1 x 107 2 x 107
  Enzymes. Restriction enzymes purchased                                cells ml. RNA separated formaldehyde-agarose
Boehringer Mannheim Biochemicals (Indianapolis, Ind.)                         gels. denaturation 0.05 M NaOH renaturation New England BioLabs (Beverly, Mass.). T4 DNA ligase                           0.1 M Tris (pH 7.5), RNA transferred GeneScreen
purchased New England BioLabs. enzymes                              (New England Nuclear, Boston, Mass.) capillary blotting
used according instructions supplier.                               1x SSC (0.15 M NaCl, 0.015M sodium citrate). RNA   DNA preparation analysis. Yeast genomic plasmid                         cross-linked membrane UV irradiation (10). Probes
DNAs prepared described previously (28). E. coli                          hybridized dextran sulfate method described
plasmid DNA prepared method Holmes                              GeneScreen instruction manual. Additional probes
Quigley (29) Birnboim Doly (2). DNA restriction                            hybridized membrane stripped 1 x
fragments separated electrophoresis                               SSC-50  formamide 80°C 2 h. RNA  VOL. 1 l, 1991                                                                         SPT5 GENE S. CEREVISIAE           3011
 lane normalized hybridization TUB2 DNA             acid, 1.25 mM EDTA). electrophoresis, gel (plasmid pYST138; 60).                                            soaked sequentially 20 min 0.25 M HCl, 0.5 M
   Plasmids. Vectors used SPT5 subcloning YCpS0          NaOH-1.0 M NaCl, 1.5 M NaCl-1.0 M Tris (pH 7.4).
(34) pMS37 pRS316 (57) pMS18 pMS23.               DNA transferred nitrocellulose capillary
Subclones tested SPT5 function transforma-         blotting 4x SSC. Radiolabeled pMS4 DNA hybridized tion spt5 mutant strain MS63(pMS18) FY298             chromosomes result composition: chro-
(pMS23, pMS37). integration cloned yeast DNA,          mosome IV (CEN4), chromosome V (URA3), frag- constructed plasmid pMS15 cloning 4.0-kb                ments chromosome VII (pBR322, URA3), chromo-
HindIII-KpnI fragment pMS4 HindIII-KpnI sites         XIII (SPT5). Linkage SPT5 centromere integrating plasmid pRS306 (57). study effects      markers chromosome XIII determined tetrad multiple copies SPT5 gene, plasmid pMS24            analysis. sptS-24 scored ability suppress constructed cloning 4.8-kb HindIlI-EagI fragment         phenotype conferred 8 insertion mutation his4-
pMS4 HindIII-EagI sites vector pCGS42             9128. secS9 allele MS113 derived strain
(Collaborative Research), contains 2,um circle.     SF402-4D.
Plasmids used probes follows: HIS4, pFW45,            DNA sequence analysis. Restriction fragments se- BglII-SalI restriction fragment internal HIS4 cloned      quenced cloned vector M13mp18 M13mpl9
pBR322 (66); LYS2, pFW47, BglII-XhoI restriction            (48). nucleotide sequence determined fragment internal LYS2 cloned pBR322 (13),              method Sanger et al. (54), using  35S]dATP (Amersham)
pFW112, EcoRI-BglII restriction fragment 5'           Sequenase version 2.0 kit (U.S. Biochemical Corp.,
region LYS2 cloned pBR322 (13); TUB2, pYST138,          Cleveland, Ohio). 12 cases, conve- 0.24-kb BglII-KpnI restriction fragment internal TUB2        nient restriction sites, 20-base oligomers synthesized
cloned pGEM vector (60); SPT5, pMS22,              (Mark Fleming, Biopolymers Laboratory, Department 4.0-kb HindIII-KpnI fragment pMS4 cloned pBR322.          Genetics, Harvard Medical School) used primers.
   constructed fusions SPT5 E. coli lacZ gene     complete DNA sequence determined using integrating plasmids containing polylinker followed       strands. lacZ gene URA3 gene selectable marker            Indirect immunofluorescence. indirect immunofluores-
(42). Plasmid pBM68 constructed cloning 4.0-kb         cence experiments, used tetraploid cells HindIII-KpnI restriction fragment pMS4 HindlIl        larger haploid cells. tetraploid strain containing KpnI sites YIp356R; SPT5-lacZ fusion gene              SPT5-lacZ fusion constructed steps.  contained pBM68, designated SPT5(1004)-lacZ, encodes           constructed haploid strains containing SPT5(1004)-lacZ 1,004 amino acids SPT5. Plasmid pMS50            fusion transforming strain BM418 uracil prototrophy
constructed cloning 3.7-kb HindIII-PvuII restriction       pBM68 DNA linearized digestion fragment pMS4 HindIII-SmaI sites YIp357R;          StuI.  stable integrant transformation, SPT5-lacZ fusion gene contained pMS50, designated          BM437, crossed strain FY120 yield SPT5 strains
SPT5(917)-lacZ, encodes 917 amino acids SPT5.        carrying SPT5(1004)-lacZ fusion. strains
Plasmids pBM68 pMS50 unique StuI                  (BM443 BM444) mated form
restriction site URA3 gene unique PstI site   diploid BM448. isolated diploids homozygous SPTS gene useful directing integration        MAT UV irradiating BM448 (300 ergs/mm2) screening
plasmids URA3 SPT5 genes, respectively,             diploids mate cells. Mating transformation experiments.                                       MA TalMA Ta diploid BM454 MA TaIMA Ta diploid
   observed E. coli strains carrying SPT5 DNA          BM455 yielded tetraploid strain BM467, carries
high-copy-number plasmids formed unusually small colo-            copies SPT5(1004)-lacZ fusion. Strain BM339,
nies.                                                             similar BM467 does contain SPT5-
   Construction spt5 null allele. construct sptS     lacZ fusion, constructed method.
null allele, sptSA202::LEU2, replaced 0.8-kb Sall-            Cells prepared immunofluorescence SalI restriction fragment pMS23 2.2-kb SalI-XhoI        method Kilmartin Adams (35) modifications
restriction fragment containing LEU2 gene (1) gener-       described previously (61). SPT5-p-galactosidase fusion
ate plasmid pBM19.  3.1-kb PvuII-PstI restriction        protein identified incubating prepared cells fragment pBM19, contains LEU2 gene                 monoclonal rabbit anti-,B-galactosidase antibody (Cappel,
flanked SPT5 sequences, used transform              Malvern, Pa.) diluted 1:10,000 fluorescein-conjugated
diploid BM60 leucine prototrophy. Strain BM80 stable      goat anti-rabbit antibody (Sigma, St. Louis, Mo.) diluted
Leu+ transformant resulting recombination            1:250. DNA stained fluorescent dye 4',6'- fragment genome copy SPT5        diamidino-2-phenylindole dihydrochloride (DAPI). Fluores-
gene replaced null allele (53). structure   cent staining visualized using Zeiss Photomicro-
SPTS loci diploid BM80 verified Southern            scope III equipped epi-illumination fluorescence hybridization analysis (data shown). phenotype         Zeiss Neofluar 63x lens, numerical aperture 1.25, pho- spt5 null allele haploids analyzed following           tographed Kodak TMAX-400 film. exposure time
sporulation BM80 dissection tetrads.                    micrographs fluorescein fluorescence experi-
   Mapping SPT5. method Carle Olson (6)            mental control strains 30 s.
used prepare chromosome-size DNA strain                     Nucleotide sequence accession number. GenBank ac-
YPH149. Chromosome VII YPH149 fragmented              cession number SPT5 sequence M62882. RAD2 allow yeast chromosomes resolved discrete bands alternating field gel electro-                               RESULTS
phoresis (24). DNA separated clamped homogeneous
electric field (CHEF) gel electrophoresis (9) 0.9           sptS mutations alter transcription. Recessive mutations agarose 0.5x TBE buffer (45 mM Tris base, 45 mM boric          SPT5 identified suppressors insertion
 3012        SWANSON ET AL.                                                                                                                          MOL. CELL. BIOL.

                                                                                       
                               K/S4       hls4--912 6                                                          L YKS              /ys2i- 128
                                                                                                                                                                                                                          Q-                      -
                                                                                                                                                    
                                                                                                         S          t.
                                                                                                                             C.   K,fI

                                                                                            L KS2        --O           mm



                 HIS4     (     _             7




                 FUB2                 -m                                                    L YS2                                 *
                           1    2     3   4    5   6
       B.
                 TATA
        UAS                                                                                              1 2           3          4          5 6

                                                                             B
              SPT5 *                                       H js
                                                                               UAS    TATA                                                                                                                                  :1,                   LY52
               spf5                       _Hiis'
                                                                                     spT5                                                                   Lys

  FIG. 1. Effects spt5 mutations transcription his4-9128.
  Total yeast RNA subjected Northern analysis. membrane hybridized HIS4 probe pFW45                                                                                      spf5
rehybridized TUB2 probe pYST138. Approximately 2.5 ,ug RNA loaded lanes 1 3, approximately 10 ,ug loaded lanes 4 6. strains used (left right) FY98,        FIG. 2. Effects spt5 mutations transcription lys2-1288.
FY360, FY382, FY120, FY300, FY276. (B) line depicts           Total yeast RNA subjected Northern analysis. structure his4-9128. gray box represents HIS4 open       membrane hybridized mixture LYS2 probes
reading frame. lines represent flanking DNA. box      pFW47 pFW112 rehybridized TUB2 probe solid triangle represents solo 8 element. Labels indicate   pYST138. smaller L YS2 RNA abundant, relative positions known TATA boxes (TATA) upstream          pFW47 probe contained approximately 10-fold counts activating sequences (UAS). lower lines depict probable         minute pFW112 probe. Approximately 2.5 ,ug RNA origins transcripts SPT5+ sptS strains.                       loaded lanes 1 3, approximately 10 ,ug loaded lanes
                                                                        4 6. strains used given Fig. 1A. (B)
                                                                        line depicts structure lys2-1288. gray box
                                                                        represents L YS2 open reading frame. lines represent
mutations his4-9128 lys2-1288 (19, 64). determine                flanking DNA. box solid triangle represents solo 8 phenotypic changes spt5 mutants result              element. Labels indicate relative positions known
alterations transcription, performed Northern (RNA)               TATA boxes (TATA) upstream activating sequences (UAS).
hybridization analysis. results (Fig. 1 2) demon-               lower lines depict probable origins transcripts SPT5S
strate sptS mutations cause altered transcription          spt5 strains.
his4-9128 lys2-1288.
   SPT+ background, transcription his4-9128 ini-
tiates 8 initiation site results mRNA          transcript approximately 580 bases (Fig. 2A, lane 4),
longer wild-type HIS4 mRNA (27, 58; Fig. 1).               probably initiation L YS2 initiation site 5' portion transcript contains frame translation             termination 8 transcription termination site (13; Fig.
initiation termination codons presumably prevent              2B). spt5 mutant strains, second transcript normal translation HIS4 coding region (58).              produced (Fig. 2A, lanes 5 6). spt5-194 mutants, sptS-194 spt5-8 mutants, shorter transcript comi-            second transcript easily seen; spt5-8 mutants, grated wild-type HIS4 mRNA produced                     new transcript low level seen
addition 8-initiated transcript (Fig. 1A, lanes 5 6).        clearly longer exposures.  strains levels transcripts roughly equal.               equally Lys'.) mRNA slightly shorter size new transcript indicates spt5 mutations allow          wild-type LYS2 transcript likely result tran-
transcription initiation normal HIS4 initiation site (Fig.       scription initiation near 8 initiation site elongation
1B). alteration his4-9128 transcription seen         LYS2 gene (Fig. 2B). Mutations SPT6 spt6 htal-htbl (histone) mutants (12, 13).                          HTAI-HTBI cause similar changes lys2-1288 transcription
   Mutations SPT5 affected transcription lys2-1288.          (12, 13). SPT7 strains, transcription lys2-1288 resulted short           Transcription sequences examined.  VOL . 1 1, 1991                                                                                                              SPT5 GENE S. CEREVISIAE        3013

                                                                                                                :4

                                  :1::
                                                                        .                           C




                                                                        IQ ~                          ~               ~


                                                                                                                             pMS4        +
                                                                                                                             pMSi8       -
                                                                                                                             pMS23      +/-
                                                                                                                             pMS37       -
                                                                LEU2
                                                             \                ,/                      ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~                                                                                                                    pBMl9


  FIG. 3. Restriction map SPT5 locus. line represents SPT5 locus restriction sites. thinner portion line
represents vector sequences. lines represent DNA fragments subcloned test SPTS function. Plasmid pBM19 used construct sptS null mutant.


level wild-type HIS4 L YS2 transcripts slightly                 gene  Materials Methods). Integration allele
reduced spt5 mutations (Fig. 1A, lanes 1 3; Fig. 2A,                     diploid strain BM60 resulted strain heterozygous
lanes 1 3). reduction level                          null allele. sporulation tetrad dissection length Ty transcripts spt5 mutants (data shown).                   strain (BM80), viability segregated 2:2 (9 10 tetrads)
Similarily, spt6 htal-htbl (histone) mutations                      1:3 (1 10 tetrads). cases, viable spores affect level length Ty transcripts (4, 13).                     Leu-, indicating carried wild-type SPT5 gene.
contrast, spt mutants different phenotypic class (spt3,                    SPT5 gene essential growth.
spt7, spt8, sptl5) abolish greatly reduce level                     Altered SPTS gene dosage causes mutant phenotypes. Al- length Ty transcripts (17, 65, 66).                                       tered dosage SPT6 HTAI-HTBI locus confers
   Isolation SPT5 gene. SPT5 gene clone                          Spt- mutant phenotype (12, 13, 45). test isolated library yeast DNA (52) screening                     altered SPT5 gene dosage causes similar phenotypes, plasmids complemented spt5 mutant phenotype.                       constructed set isogenic strains 
recipient strain, MS11 (spt5-8 lys2-1288 ura3-52), Lys'                     duced increased copy number SPTS gene. suppression lys2-1288 spt5-8. sptS-8                     strains tested suppression insertion
recessive, transformants MS11 carry wild-type                      mutations his4-9128 lys2-1288. diploid strain (BM80)
SPT5 gene plasmid Lys-. Lys- candi-                         contained copy SPT5 gene (SPT5SI
dates identified screen approximately 15,000                      sptSA202::LEU2) strong Spt- phenotype   Lys')
Ura+ transformants; contained DNA insert,                        (Fig. 4). haploid SPTS+ strain (MS191) transformed plasmids designated pMS4.                            multicopy SPT5 plasmid (pMS24) weak Spt- pheno-
plasmid conferred Spt+ phenotype retransformed                         type  ' Lys+'-) (Fig. 4).  increase strain MS11 transformed strain MS63,                         decrease SPT5 gene copy number causes Spt- contains different spt5 allele.                                        phenotype.
   confirmed pMS4 contained SPT5 gene                              Genetic mapping SPTS. determine SPT5 demonstrating cloned DNA directed integration                    previously identified gene, mapped combination
plasmid SPT5 locus. Plasmid pMS15, integrating                       physical genetic methods. determine chromo-
plasmid contains restriction fragment pMS4,                    SPT5 gene resides, DNA prepared
linearized unique NruI site cloned DNA                     strain YPH149, chromosomes separated used transform FW1237 (SPT5+ ura3-52 iys2-1288)                          CHEF gel electrophoresis (9) described Materials uracil prototrophy. Ura+ transformant (MS98) crossed strain MS17 (sptS-24 ura3-52 iys2-1288), tetrads dissected. 17 spored 
spored tetrads, Spt+ Ura+ phenotypes cosegregated tetrad, demonstrating pMS15 DNA tightly
linked SPTS locus.
   characterize SPTS gene greater                         C  PT-5 -,-       ,l.        t -1r                    b) sp15-/-94
subclones constructed tested SPT5 function                            c)    F T54        2caSPT5                                 d) SJT:5 (CEASt-P T5 )
(Fig. 3). HindIII-KpnI fragment (pMS23) par-                               .../&S  f.                                            f spto5A ,; SPT5
tially complemented spt5-194 allele, sub-                                                                                    )


clones fully complemented mutant phenotype, suggest-
ing SPT5 gene occupies cloned 3.9-kb                        FIG. 4. Suppression insertion mutation Iys2-1288 al-
DNA fragment.                                                                  tered SPTS gene dosage. Patches strains genotypes
   Construction analysis spt5 null mutant.                        indicated grown YPD plate replica plated constructed spt5 null allele marked LEU2 gene,                       plate shown, contains SC-lys medium. strains grew spt5A202::LEU2, deleting SalI-Sall restriction frag-                        synthetic complete plate  shown).   MS189(pCGS42); (b)
ment internal SPT5 (Fig. 3) replacing LEU2                      FY300; (c) MS191(pMS24); (d) MS190(pMS4); (e) BM60; (f) BM80.
 3014    SWANSON ET AL.                                                                                                           MOL. CELL. BIOL.

                                                                                   TABLE 2. Mapping SPTS tetrad analysisa
                                                                ZcAN#                                                       SegregatingPD
                                                                       Crossb Sb
                                                                               markers                     NPD      TT           ~~~~Linkage Gene-CEN
                                                                                                                                             (cM)
XJII                                                                              markers                                  ~~~~~Gene-gene
  FIG. 5. Genetic map position SPT5. SPT5-CEN13 dis-               1       spt5, sec59       76        0       4           3
tance strain dependent  text).                                            spt5, lys7        41        0      39          24
                                                                                  secS9, lys7       43        0      37          23
                                                                                  spt5, trpl        42       38       0                       <0.6
                                                                                  secS9, trpl       39       36       5                         3
Methods. Southern hybridization analysis demonstrated                        lys7, trpl        20       20      40                        25
SPTS located chromosome XIII (63).                                         trpl, ura3        36       32      12                         8
                                                                                  sptS, ura3        35       34      11                         7
   Tetrad analysis showed SPT5 located left               2       sptS, sec59       42        0       9           9
arm chromosome XIII, tightly centromere linked (Table 2;                       sptS, lys7        19        0      32          31
Fig. 5). order SPT5-CENJ3-SEC59 determined                             sec59, lys7       28        0      23          23
examining tetrads SPT5 CEN13 recom-                              spt5, trpl        23       21       7                         7
bined; case (seven tetrads), SEC59 CEN13 did                         secS9, trpl       23       26       2                         2 recombine. order consistent                            lys7, trpl        11       15      25                        25
segregation SPT5 tetrads CENJ3 SEC59                           trpl, ura3        23       20       8                         8 recombined. Similarly, order SPT5-SEC59-LYS7                              spt5, ura3        19       20      12                        12 established scoring LYS7 segregation tetrads                 PD, parental ditype; NPD, nonparental ditype; TT, tetratype. sptS-24 SPT5 SEC59 recombined. 13 tetrads,               allele scored ability suppress his4-9128; secS9 scored SEC59 LYS7 recombined  SPT5                    temperature-sensitive lethality 37°C; trpJlW ura3-52 scored LYS7 recombined 12 times. results, conjunc-                tryptophan uracil auxotrophies, respectively; lys7 scored                                                                         mating spore clones lys7 strains (K396-11A K396-22B) scoring
tion previous work showed L YS7 maps phys-               diploids complementation lysine auxotrophy. TRPI allele,
ically right arm chromosome XIII (23), indicated              tightly linked CEN4 (<1 cM; 44), URA3 allele, SPT5 resides left arm chromosome XIII.                   tightly linked CENS (8 cM; 44), used calculate map distance
Additional meiotic linkage analysis demonstrated SPT5              SPTS CEN13.
                                                                          b Cross 1 MS113 x MS192; cross 2 MS113 x MS193. allele centromere-linked TSMOJJJ locus, cross (82 tetrads), SPT5 mapped 4.9 centimor-
gans (cM) TSMOJJJ (63).  based unique map position, SPT5 previously uncharacterized               concentration acidic residues amino terminus:
gene S. cerevisiae.                                                  residues 1 220 net charge -63. region 81
   map distance SPT5 CEN13 strain                   amino acids (residues 137 217) 60  glutamic dependent; representative crosses shown Table 2.             aspartic acid included stretches 11 20 consecutive cross strain MS113 strain MS192,               acidic residues. amino terminus included CENJ3-SPT5 recombinants 80 tetrads (<0.6 cM; Table 2).               consensus sites phosphorylation casein kinase II (37) contrast, strain MS113 crossed strain                    positions 122, 188, 241, 377. carboxy terminus MS193, seven CEN13-SPT5 recombinants 51                   predicted SPT5 protein (residues 887 1063) 31 
tetrads (7 cM; Table 2). Analysis SPT5 segregation              glycine contained 15 copies amino-acid se-
respect different centromere-linked markers, TRPI (chro-             quence S-T W-G-G Q (Table 3).
mosome IV) URA3 (chromosome V), showed                        search National Biomedical Research
difference strains MS192 MS193 lies                  Foundation Protein Sequence data base (version 26; Novem-
CEN13-SPT5 interval (Table 2). Similar results ob-                 ber 1990) did reveal proteins significant sequence
tained SPT5 crosses: CEN13-SPT5 map distance               similarity SPT5, exception number calculated <1 cM approximately 5 cM (63).              generally acidic glycine-rich proteins, including nucleolins observation genetic map position SPT5               (38). proteins data base contained strain dependent indicates polymorphisms                 amino-acid repeat S-T W-G-G Q.
(possibly insertions inversions) CEN13 region                 carboxy-terminal repeat region critical SPT5 strains.                                                           function. Results subcloning experiments suggested
   SPT5 encodes acidic protein carboxy-terminal               SPT5 carboxy-terminal repeats required repeat. nucleotide sequence SPT5 gene                    SPT5 function. deletion removed 6 15 repeats
determined method Sanger et al. (54). open                (pMS23) impaired complementation spt5-194 (Fig. 3) reading frame 3,189 bp (Fig. 6) consistent              eliminated complementation spt5 null mutation.  size SPT5 mRNA (3.4 kb; 63) results                  deletion removed 15 repeats (pMS37) eliminated
 subcloning experiments (Fig. 3). nucleotide sequence               complementation spt5-194 (Fig. 3) spt5
predicted 1,063-amino-acid protein 115,649 Da             null alleles.
 striking features: acidic amino terminus car-               examine importance SPT5 peptide
boxy-terminal amino acid repeat. entire SPT5 protein                repeats, constructed SPT5-lacZ fusions: SPT5(1004)-
 predicted isoelectric point 4.95,             lacZ encodes residues 1 1004 SPT5 includes 

   FIG. 6. Nucleotide sequence SPT5 gene predicted amino acid sequence gene product. Nucleotides numbered left; amino acids numbered right. termination codon represented asterisk. runs 11 20 consecutive acidic
residues 15 copies amino-acid repeat underlined. PvuII KpnI sites used construct SPT5-lacZ fusions SalI sites used construct spt5 null allele indicated.
 VOL. 11, 1991                                                                                                   SPT5 GENE S. CEREVISIAE     3015

                   1                      CTCTTAAGCCACTTCCCCCAAATCCACCTCTCTGCCACAGMCTAATAACCATCCACCATAMTCATCTATTACTCTTAAATTAT
                  86 TCATCACTATCAGTAACTGGCATGTCCATCGTACCAGTT§  CTCGTAAATCTATTACGTCAGTTCCTTCTATAATGACGTCTTCATTCTCACCAGTTT§CCAAMTTG
                 191TCCGCTCTAGTTGCAAATCCTTGAAGACCTTGGTAGTTCATTAACGGTCATATCATGGTCCAGACTGGATTCCGCATATTTTCCAGAAMCATCTTCAACTT
                296 CGATAGGTACTTTCGGGTTCTCGAATAGCTCTACTCTTTCATAACTAACCTTAGTCGAI GICTCATTGAAAAACTCGCAAGGTAM AGGTGACCTTGCGG
                401 MrrMATGCTGACACCTCCATGCGTAATTGTTATTATATATATATATGATAGTATAM CATACTTGTTCCTTCTAAAGTCACCCCGCCTGATATGCGACATA
                506 GMAAAAATGATAAAGTCAAATTG    GTAGCATT      GACAAGACCATTCATAC AAGCTAGTACAGCAGCAAGAAGAGACGGGCC
                                                                                                             TGTTGTGATAATT
                611 ATGAGTGACAACTCCGACACAAACGTGAGCATGCAGGACCATGATCAACAAM| CTGATCCCGTAGTCGTTCCGCAGTCAACTCACACTAAAGATGAAATACT
                        M S D N S D T N V S M Q D H D Q Q F D P V V V P Q S T D T K D E N T                                           35
                 716 AGTGACAAAGAACTGTTGATATGCATGCAACOAGTACAG         AACCATATTCCCCCTrTAGATGGGGMAAGAAAGA
                                                        AACGTGCAGAAGTAC
                     S D K D T V D S G N V T T T E S T E R E S T S N P P L D G E E K E                                              70
                 821 GCAAAATCTGACCCACAGCACCTGAGGATAATGCAGAAACGCCGCCCACACACCACCI TrCATCTAGTAACGOGCCTGCTACAGATGATGCCCAAGCAACTTTG
                     K S E P Q Q P E D N E T T E Q V S S S N G P T D D Q T L                                              105
                 926    MTACOGATTCATCCGAAGCAAATGAAATTGTCAAMGAAGGAGAGCCTCTGATGAAACGAAGAGACCTCGCCGAAGAGACACCAAAACAGTGATGGTGATACC
                        N T D S S E N E V K K E E G S D E R K R P R E E D T K N S D G D T                                           140
                                                                         ATGACGATAACMCTCCACTAAGCGTCGTCAG
                                                            GTAAGOGACWAGCA
                1031 AAAGATGGCGATCAAAGATGAAGACGAGTAACCAGACGAT        C
                     K D E C D N K D E D        n F nD D D        D D F D D D D E P T K R R R Q                                       175
                1136                                                                                                    ICATTACCCAT
                                                                                                             GTGA__[____ACGMGC
                        E R N R F L D E E V S D                  F nD E      F       n   F FE D S E L V R E G F T H               210
                1241    OGTGATGATGAAGATGACGAAOCAAGTOCTCCACOCCCCAAGAAACGAAATTACATAGACAACTOGACCAAGACMGAACAAACTTCAGAAAAGMACGCT
                        G D D E D D E S P G R R D D R L H R Q L D Q D L N K T S E E D                                           245
                1346    CAAAOGTTACeCAAAGAATTAACCCAGCCTTACCCTAGACCAOCTCCAAOCAATACCGTCCTOCTCTCAAGATOGTTACGTCCCCCACAGAGGI |CTCCTACCA
                     Q R L K E L R E R Y C R S S S K Q Y R Q D G Y V P Q R F L L P                                              280
                1451 ACTCTTGATACACCTACCAMCGCMTGTOCOCTCCAGACCAGCTAAAGAAAOAACGTTCGATTTAAAAAAAT
                                                                                  CC      TCAAM ATAGGCATG
                     S V D T T V G V R C R P G K E K E L R K L L K K K F N L D R M                                              315
                 S56W   CGTMGAAAAAACTGMAAATTTTATCCA llTTTTCCAACGTAACACACCAGTCTATATCGACCCTGACGTTATT GAAM AATTTTTMT
                        G K K K L K L S F Q R D N Y T C R Y E P K Q S V E K F C N                                           350
                1661                                                 CAAGAATTACCTCTATTACTAAAACCAACAMTCACAATCTAGATGTTGCTTTGIGIACCMCMCT
                        G V P D Y S Q K L L P V Q E L P L L L K P N K S D D V L E E G                                           385
                1766    AOCTACGTTCGTATTMGACACACCATCTATAAGCGTGAMTAGCTATOGTCGACCAAATTAGTGAGAATMAATAAAGTTATCCTGMMTTGTTCCTCGTCTG
                        S Y V R K R G Y K G D L M V D Q S E N N L E V M L K V P R L                                           420
                1871    CATTATGGTAAATTCGACGAAATTGATCCAACAACACAOCAACCTAAATCCAGAAGACCAACTTTTGCTCATAGAOCACCACCGCAATTATTTAAMTCCAACAATG
                        D Y G K F D E D P T T Q Q R K S R R P T F H R P P Q L F N P T M                                           455
                1976    CCTCTAACATTACACCAAGCTAACCTGTACAAAACCATCATCOCCACTTTAMTATGAACTGAAGATrATATCGATGGTTATCTGTATAAGTCM|CAGAATT
                        L R L D Q N L Y K R D D R H F T Y K N E D Y D G Y L Y K S F R                                           490
                2081    CAAAGTGACCAAAATATTCACCCAACTGTGGAOGAATTGCAAGCATTCGGTTCCAACAGACCOCCGGTAGATCTMCATCAGMCACAATCAATCAAG
                     Q H V E T K N Q P T V E E L R F G S K E G V D L T S V S Q S K                                              525
                2186 AACOCTCAACCTOCAAACCTCACM CCAOCCACGTGATCGTATCGAAGTTCTAAATGGTGAACAACGTCGTTCCAAGGCTATTGTAACAAGAAcCAcGAAAGAT
                     K Q K V T F Q P C D R E V L N C E Q R G S K G V T R T T K D                                              560
                2291 ATr CTACTATCAAACTAMTGCTTACAACOCCTCTAGAAMCCTATCTCTACTCTGAGCAM TMTCGAACCTCGTGATCACGTTACTGTcATCAATGGT
                        T K L N C F T T P L E F P S T L R K F E P G D H V T V N G                                           595
                2396 CA CT GT ACTC M M C CC CT CAT                         CAaTTAACAAATCTG
                     E H Q C D G L V L M V E Q C Q V T F M S T Q T S R E V T T N N L                                              630
                2501 TCCAAATCCATCGACACTACACCTACATCAA CTCATATOCCTCATGCATATCGAATTGGTCTAAAAATGCTTOCTTArATTTcAAcCTCCCCACGAT
                     S K S D T T T S S E Y L H D V E L S K N V C I Q G H D                                              665
                                                          aiII
                2606    ATMCAACMGTTATTGATGAAACTOGTAAAGTGTCGCAAMTTACGAAGCTCTATMGATAAACMTAAATACTGCTCGTGCACGCGTTIIICTAGTGTCGATCCA
                        F K V D E T G K V S T T K C S L S K N T R R V S S V D                                           700
                2711 AATIACATGCTCAAATCGTGTACATGTACAGACATCAC OCGGAGCOTCCTCATAACATACAAACCAAAATTffTTTGMCA
                     N G N E K G D T V E K V G S R R E C Q V L Y Q T Q Q F V V S                                              735
                2816 AAAGTTCGTMGAAATCTACTMCTTMGTGTCCCTATACGTGC CGGCATCC
                                                                  AACGACM GTTM
                                                                        TAT  TMGTACAAAGGATCTMGTMAA
                     K K V E N G V F V V N P S N V E V S K D N M L S N K M D L S K                                              770
                2921 ATGAATCCAGAAATCAMCTAAATGOGACCTCCATCATCTAAGACATTCCAACAACCCATCCAGTCCAGAGGAGGTCGTGAAGTTOCACTCGCACAACAGTA
                     V N P E I S K M G P P S S K T F Q Q P Q S R C G R E V L G K T V                                              805
                3026 AGATCGTTCTG GCTCCTGATTCCTCGM
                                  CGTCTT MT                                   AGACAACACATACAATT
                     R R S G Y K C Q L G V K D V N G D K T V E L H S K N K H T                                              840
                3131 GACAACATAAGTTMCATATACAACCGTGAGGGAGTGMOTATCAGTATGTATOTMTA GAGTGTAGATAAGTCCAcAGMCAATcGGCCCA
                     D K H K L T Y Y N R E G G E G T Y D E L V N R R G R V P Q R M G P                                              875
                3236    AGTTACGTCAGTGCCCCMCAAGACATCCCCACTOCGGCTATTGCAGCAGGTCTccGCGCTACCTMCTTGTcCTTAGCGGTGGTATGACACCAGGATGGAGCTCC
                        S Y V S P R N M T G G C T S S G L S G G M T P G W S S                                            910
                                            P-JII
                3341    TTCGATGGTGGCAAACACCAGCTGTAMATGCGCATGGAGGCTCAGGTOGTCGcGGTGTCTCCTCATGGGGTGGTGCTTCCACTTGGGGTGCCAAGGTAATGGA
                        F D G G K T P V N H G G S G G G G V S S w C C S T V C C-                              n       G N G        945
                3446    GGTGCATCCCCMGGGGCGGTGCTGGCGTCCTCCCCGTCTAGMGGCGGCCAAGccGTACTGGTGCTAMCTAMGGTcGTGGTGCTrCAGCCTGGGCTAACAAA
                        G S W C C G G G S V C C Q G T G T S T W G C S W C N K                                            980
                                                                                                    42nI
                3551 TCAAGTTGCGCGGCTGCATCCACTTGGGCGTCGGGTGGGATCMTAATGGTGCCATGTCTACTTGGGGTGGTACCGGTGATAGGTCAGCCTACGCGGGGCCTTCC
                     S S w C C S T W S C G E S N G M S T W C T G D R S Y C C  S                                             1015
                3656 ACCTGGGAGGAATAACAATAATAAAATACMAAGAATGCGGCAGCTTCTGCATGGGGTAACCAAGACGATGGAATAGGTCTGCTTGCAACAACCAAGAAT
                     T W C Q N N N K S T R D C G S                   C     Q D D G N R S W N N Q G N
                                                                                     L                                                  1050
                3761 AAGTCAAACTATGGTGGTAACAGTACATGGGGAGGTCATTAATCACCAAAAGAGACMCAATATCACCCAAG CAAG MTCAATAAAAAAACMMTATTACCA
                     K S N Y C C N S T W C. C H o                                                                                       1063
                3866 rCrATAATAATACTTATCMAAmATCrATCrmCrATCAAATArTCMATCTrCATCrTCCArCATC
 3016       SWANSON ET AL.                                                                                                     MOL. CELL. BIOL.

              TABLE 3. SPT5 amino-acid repeat'                                                      DISCUSSION
       Position                                      Sequence
                                                                                   Mutations SPT5 initially isolated genetic selec-
931 ............                             S S W G G                        tions designed identify genes required normal
937 ............                             S T W G G                     Q    transcription S. cerevisiae (19, 64). Previous genetic
948 ............                             S W G G                        results suggested SPT5 gene related func-
958 ............                             S W G G                     Q    tionally SPT6. results include observations 969 ............                              S T W G G                       spt5 spt6 mutations suppress set mutant
975 ............                              S W G N                    K    alleles, cause double-mutant lethality haploid cells, 981 ............                              S S W G G                       fail complement diploid cells (26, 63, 64). similarity
987 ............                              S T W S                    G    spt5 mutant phenotypes spt6 1000 ............                             S T W G G                    T    htal-htbl (histone) mutants (4, 12, 13, 19, 26, 45, 46, 62) led
1009 ............                             S Y G G                       analyze SPT5 gene product step 1015 ............                             S T W G G                    N    understanding roles genes transcription.
1032 ............                             S W G N                    Q       current work extends genetic similarities 1043 ............                             S W N N                    Q    SPT5 SPT6 genes revealed interesting
1052 ............                             S N Y G G                    N    features common SPT5 SPT6 gene products.
1058 ............                             S T W G G                    H     spt5 spt6 mutations cause similar alterations                                                   T                           transcription his4-912b lys2-1288 alleles (Fig. 1
  Consensus .............S W G G                                         Q    2; 13). Second, sptS spt6 null mutations cause
   matches ............                 15 12 13 13 11               9    lethality (13, 45).  increased decreased gene dosage
  predicted SPT5 amino acid sequence includes 15 copies          SPT5 SPT6 confers similar mutant phenotypes
amino-acid repeat carboxy terminus. serine repeat   (Fig. 4; 13). Finally, judged immunofluorescence
numbered Fig. 6. Residues boldface type match consensus,     microscopy fusion proteins, SPT5 SPT6 appear derived empirically.                                                        nuclear proteins (Fig. 7; 61).
                                                                                   nucleotide sequence SPT5 gene revealed
                                                                                similarities SPT6 gene. predicted proteins                                                                                 high concentration acidic residues amino terminus.
copies repeat; SPT5(917)-1acZ encodes residues 1                      sequence SPT5 predicted region 81 amino acids
917 SPT5 contains copies repeat (Fig. 6).                   60  glutamic acid aspartic acid. Likewise, determine SPT5-lacZ fusions com-                        SPT6 nucleotide sequence revealed 50  70
plemented lethal phenotype conferred spt5 null                        amino acids glutamic acid aspartic acid (61). mutation, constructed diploid strains containing                     acidic domains proteins contain number poten- SPT5-lacZ fusions integrated sptSA202::LEU2                          tial sites phosphorylation casein kinase 11 (37).
allele  Materials Methods). Tetrad dissection                           class proteins extremely acidic domains
strains contained SPT5(1004)-lacZ fusion                        proteins thought interact chromatin  refer-
(MS195) SPT5(917)-lacZ fusion (MS194) resulted                        ence 15 review). proteins, nucleolin, 4:0 segregation viability.  spore clones                   acidic amino terminus glycine-rich carboxy
contained SPT5(917)-lacZ fusion gene extremely                         terminus (38), similar SPT5. transcription factors,
sick, taking 5 7 days form colonies 23°C  opposed                   including yeast proteins GAL4 (39) GCN4 (30, 31), 2 days wild type 3 days SPT5(1004)-lacZ                      acidic domains required activation strains]. Spore clones carried SPT5-lacZ fusion                     transcription;  acidic domains generally grow 30 37°C phenotypically Spt-.                         extensive acidic predicted Western immunoblot analysis indicated strains carrying                      SPT5 SPT6 proteins. human nucleolar transcription fusions (MS194 MS195) contained approxi-
                                                                                factor hUBF does contain highly acidic carboxy-terminal
mately SPT5-p-galactosidase protein
                                                                                region (33).
                                                                                   carboxy-terminal 132 amino acids predicted
(63).  repeat domain appears critical                   SPT5 protein include 15 copies amino-acid repeat
SPT5 activity.                                                                  S-T W-G-G Q. Deletion SPT5 sequences encod-
   SPT5 encodes nuclear protein. characterize                  ing 15 repeats impaired SPT5 function, SPT5 protein, used indirect immunofluorescence,                           deletion 15 repeats virtually eliminated SPT5 function,
described Materials Methods, determine cellu-                     judged complementation sptS mutations. Analysis lar location SPT5-p-galactosidase hybrid protein.                     SPT5-lacZ fusion genes encoded zero results (Fig. 7A C) showed immunofluorescence                       copies amino-acid repeat indicated coincident DAPI staining nuclear DNA.                          repeat domain critical SPT5 function. analysis
treated similarly, isogenic strain fusion                    requirement repeat domain, fusions p-ga- stained (Fig. 7D F), demonstrating immuno-                       lactosidase appeared increase slightly activity fluorescence represented SPT5-,-galactosidase hybrid                         SPT5, possibly stabilizing SPT5 portion hybrid
protein. Omission anti-,-galactosidase antibody                      protein.  result does necessarily mean staining procedure eliminated fluorescein fluores-                      function repeats stabilize SPT5 protein.
cence. Previous work demonstrated ,-galactosidase                       possible roles SPT5 repeats promote
expressed yeast cells located cytoplasm                     protein-protein interactions regulate SPT5 activity. nucleus (25, 61).  observation                            gene sequences large data base
SPT5-p-galactosidase hybrid protein contained partial                       predicted proteins significantly similar repeat se-
SPT5 function localized nucleus strongly suggests                     quences, SPT5 repeat somewhat reminiscent wild-type SPT5 protein located nucleus.                       heptapeptide carboxy-terminal repeat largest subunit
 VOL . 1 l, 1991                                                                              SPT5 GENE S. CEREVISIAE              3017




  FIG. 7. Nuclear localization SPT5-,3-galactosidase. Strain BM467, containing SPT5(1004)-p-galactosidase hybrid protein  C), strain BM339, control strain lacking hybrid protein (D F), stained anti-,-galactosidase antibody fluorescein-conjugated secondary antibody described Materials Methods. Micrographs phase-contrast  D), fluorescein
fluorescence (B E), DAPI fluorescence, stains DNA (C F). Bar = 10 ,m.

 RNA polymerase II (consensus = P-T-S-P-S-Y-S).                   Previous genetic analyses spt mutants revealed num- SPT5 RNA polymerase repeats contain residues              ber similarities spt5, spt6, histone (htall phosphorylated (S, T), residues known                sptll htbl/spt12) mutant strains. Mutations disrupt secondary structure proteins (G, P),                genes suppress spectrum Ty 8 insertion
aromatic residue (W, Y). RNA polymerase repeat                 mutations cis- trans-acting mutations
present eukaryotic RNA polymerases 26 (yeast) 52             greatly reduce expression SUC2 gene Ty
(mouse) copies  reference 14 review), phosphor-          elements (4, 12, 13, 19, 26, 45, 46, 62). Furthermore, histone
ylated (5; reviewed reference 55), required vivo         gene pairs, like SPT5 SPT6, exhibit interesting dosage yeast RNA polymerase function (47), function           effects: increase decrease gene copy number known.                                                        causes Spt- phenotype (12).   model consistent gene dosage results           SPT5 SPT6 encode essential nuclear proteins SPT5 SPT6 proteins function complex              highly acidic amino termini. Given mutant phenotypes sensitive stoichiometry components.             physical characteristics, favor model  strains contain SPT5 SPT6                   SPT5 SPT6 proteins act affect chromatin
high-copy-number plasmids Spt- phenotype                 structure, influencing gene expression yeast cells.
(data shown), suggesting              Examination chromatin structure spt mutants
components putative complex. Genetic analysis indi-            begin address model directly.
cates gene product, SPT4 protein, required function putative complex.                                ACKNOWLEDGMENTS
Mutations SPT4 cause phenotypes similar sptS spt6 mutations, cause double-mutant lethality spt5             grateful Joel Hirschhorn David Eisenmann spt6 mutations, fail complement spt5 spt6              helpful comments manuscript David Eisenmann mutations (63, 64). SPT4,  distinct             bringing attention similarity SPT5 RNA
                                                                      polymerase repeat domains.
respects: gene essential growth, altered dosage          work supported National Institutes Health grant
does cause mutant phenotype, SPI4 protein            GM32967, National Science Foundation grant DCB8451649, acidic (40).                                                      grant Stroh Brewing Company F.W. M.S.S. E.M.
 3018      SWANSON ET AL.                                                                                                   MOL. CELL. BIOL.
 supported NIH training grant Genetics Program          27. Hirschman, J. E., K. J. Durbin, F. Winston. 1988. Genetic
(T32-GM07196) Lucille P. Markey Charitable Trust.                 evidence promoter competition Saccharomyces cerevi-
                                                                             siae. Mol. Cell. Biol. 8:4608-4615.
                           REFERENCES                                    28. Hoffman, C., F. Winston. 1987. minute DNA prepa-
                                                                             ration yeast efficiently releases autonomous plasmids   1. Andreadis, , Y.-P. Hsu, G. B. Kohihaw, P. Schimmel.               transformation Escherichia coli. Gene 57:267-272.
     1982. Nucleotide sequence yeast LEU2 shows 5'-noncoding          29. Holmes, D. S., M. Quigley. 1981. rapid boiling method      region sequences cognate leucine. Cell 31:319-325.               preparation bacterial plasmids. Anal. Biochem. 114:193-
 2. Birnboim, H. C., J. Doly. 1979. rapid alkaline extraction          197.
     procedure screening recombinant plasmid DNA. Nucleic            30. Hope,  , S. Mahadevan, K. Struhl. 1988. Structural      Acids Res. 7:1513-1523.                                                 functional characterization short acidic transcriptional
  3. Boyer, H. W., D. Roulland-Dussoix. 1969. complementa-             activation region yeast GCN4 protein. Nature (London)
     tion analysis restriction modification DNA E.          333:635-640.
     coli. J. Mol. Biol. 41:458-472.                                     31. Hope,  , K. Struhl. 1986. Functional dissection  4. Brown, S. , F. Winston. Unpublished data.                          eukaryotic transcriptional activator protein, GCN4 yeast.
  5. Cadena, D. L., M. E. Dahmus. 1987. Messenger RNA                    Cell 46:885-894.
     synthesis mammalian cells catalyzed phosphorylated     32. Ito, H., Y. Fukuda, K. Marata,  Kimura. 1983. Transfor-
     form RNA polymerase II. J. Biol. Chem. 262:12468-12474.              mation intact yeast cells treated alkali cations. J.
 6. Carle, G. F., M. V. Olson. 1985. electrophoretic                  Bacteriol. 153:163-168.
     karyotype yeast. Proc. Natl. Acad. Sci. USA 82:3756-3760.       33. Jantzen, H.-M.,  Admon, S. P. Bell, R. Tjian. 1990.
 7. Carlson, M., D. Botstein. 1982. differentially regulated         Nucleolar transcription factor hUBF contains DNA binding
     mRNAs different 5' ends encode secreted intracellular          motif homology HMG proteins. Nature (London) 344:
     forms yeast invertase. Cell 28:145-154.                              830-836.
 8. Chaleff, D. T., G. R. Fink. 1980. Genetic events associated      34. Johnston, M., R. W. Davis. 1984. Sequences regulate
     insertion mutation yeast. Cell 21:227-237.                   divergent GALI-GALIO promoter Saccharaomyces cere-
 9. Chu, G., D. Vollrath, R. W. Davis. 1986. Separation large         visiae. Mol. Cell. Biol. 4:1440-1448.
     DNA molecules contour-clamped homogeneous electric               35. Kilmartin, J. V.,  E. M. Adams. 1984. Structural rear-
     fields. Science 234:1582-1585.                                          rangements tubulin actin cell cycle yeast
10. Church, G. M., W. Gilbert. 1984. Genomic sequencing.                 Saccharomyces. J. Cell Biol. 98:922-933.
     Proc. Natl. Acad. Sci. USA 81:1991-1995.                            36. Klapholz, S., R. Esposito. 1982. new mapping method
11. Clark-Adams, C. D. 1988. Ph.D. thesis. Harvard University,               employing meiotic rec- mutant yeast. Genetics 100:387-
     Cambridge, Mass.                                                        412.
12. Clark-Adams, C. D., D. Norris, M.  Osley, J. S. Fassler,       37. Kuenzel, E. , J.  Mulligan, J. Sommercorn, E. G. Krebs.
     F. Winston. 1988. Changes histone gene dosage alter tran-            1987. Substrate specificity determinants casein kinase II      scription yeast. Genes Dev. 2:150-159.                               deduced studies synthetic peptides. J. Biol. Chem.
13. Clark-Adams, C. D., F. Winston. 1987. SPT6 gene               262:9136-9140.
     essential growth required 8-mediated transcription   38. Lapeyre, B., H. Bourbon, F. Amalric. 1987. Nucleolin,      Saccharomyces cerevisiae. Mol. Cell. Biol. 7:679-686.                major nucleolar protein growing eukaryotic cells: unusual
14. Cornelissen,  W. C. , R. Evers, J. Kock. 1988. Structure         protein structure revealed nucleotide sequence. Proc. Natl.
     sequence genes encoding subunits eukaryotic RNA               Acad. Sci. USA 84:1472-1476.
     polymerases. Oxford Surv. Eukaryotic Genes 5:91-131.                39. Ma, J., M. Ptashne. 1987. Deletion analysis GAL4 defines
15. Earnshaw, W. C. 1987. Anionic regions nuclear proteins. J.            transcriptional activating segments. Cell 48:847-853.
     Cell Biol. 105:1479-1482.                                           40. Malone, E. , J. S. Fassler, F. Winston. Unpublished data.
16. Eisenmann, D. M., C. Dollard, F. Winston. 1989. SPT15,       41. Maniatis, T., E. F. Fritsch, J. Sambrook. 1982. Molecular
     gene encoding yeast TATA binding factor TFIID,                cloning: laboratory manual. Cold Spring Harbor Laboratory,
     quired normal transcription initiation vivo. Cell 58:1183-       Cold Spring Harbor, N.Y.
     1191.                                                               42. Meyers,  M.,  Tzagoloff, D. M. Kinney, C. J. Lusty.
17. Eisenmann, D. M., F. Winston. Unpublished data.                      1986. Yeast shuttle integrative vectors multiple cloning
18. Farabaugh, P. J., G. R. Fink. 1980. Insertion                 sites suitable construction lacZ fusions. Gene 45:299-310.
     eukaryotic transposable element Tyl creates 5-base pair           43. Mortimer, R. K., D. C. Hawthorne. 1969. Yeast genetics, p.
     duplication. Nature (London) 286:352-356.                               385-460.  H. Rose J. S. Harrison (ed.), yeasts, vol.
19. Fassler, J. S., F. Winston. 1988. Isolation analysis        1. Academic Press, , New York.
     novel class suppressor Ty insertion mutations Saccha-      44. Mortimer, R. K., D. Schild. 1980. Genetic map Saccha-
     romyces cerevisiae. Genetics 118:203-212.                               romyces cerevisiae. Microbiol. Rev. 44:519-571.
20. Fassler, J. S., F. Winston. 1989. Saccharomyces              45. Neigeborn, L., J. L. Celenza, M. Carlson. 1987. SSN20      cerevisiae SPT131GALJJ gene positive negative              essential gene mutant alleles suppress defects SUC2
     regulatory roles transcription. Mol. Cell. Biol. 9:5602-5609.        transcription Saccharomyces cerevisiae. Mol. Cell. Biol.
21. Feinberg,  P., B. Vogelstein. 1983. technique                7:672-678.
     radiolabeling restriction endonuclease fragments high specific   46. Neigeborn, L., K. Rubin, M. Carlson. 1986. Suppressors      activity. Anal. Biochem. 132:6-13.                                      snJ2 mutations restore invertase derepression cause tem-
22. Feinberg,  P., B. Vogelstein. 1984. technique                perature-sensitive lethality yeast. Genetics 112:741-753.
     radiolabeling restriction endonuclease fragments high specific   47. Nonet, M., D. Sweetser, R. Young. 1987. Functional redun-
     activity. Addendum. Anal. Biochem. 137:266-267.                         dancy structural polymorphism largest subunit 23. Floy, K., P. Heiter (Johns Hopkins University Medical                RNA polymerase II. Cell 50:909-915.
     School). Personal communication.                                    48. Norrander, J., T. Kempe, J. Messing. 1983. Construction 24. Gerring, S. L., C. Connelly, P. Heiter. 1990. Positional             improved M13 vectors using oligodeoxynucleotide-directed mu-
     mapping genes chromosome blotting chromosome                  tagenesis. Gene 26:101-106.
     fragmentation. Methods Enzymol. 194:57-77.                          49. Peck, L. (Harvard University). 1983. Personal communication.
25. Hall, M. N., L. Hereford,  Herskowitz. 1984. Targeting      50. Rigby, P. W., M. Diekman, C. Rhodes, P. Berg. 1977.
     E. coli P-galactosidase nucleus yeast. Cell 36:1057-          Labeling deoxyribonucleic acid high specific activity vitro
     1065.                                                                   nick translation DNA polymerase  J. Mol. Biol.
26. Happel,  M., M. S. Swanson, F. Winston. Genetics,               113:237-251.
     press.                                                              51. Roeder, G. S., G. R. Fink. 1980. DNA rearrangements
 VOL. 11, 1991                                                                                     SPT5 GENE S. CEREVISIAE               3019

      associated transposable element yeast. Cell 21:239-             charomyces cerevisiae controlled SPT genes.
      249.                                                                      Proc. Natl. Acad. Sci. USA 81:2431-2434.
52.   Rose, M. D., P. Novick, J. H. Thomas, D. Botstein, G. R.        60.   Som, T., K.  Armstrong, F. C. Volkert, J. R. Broach.
      Fink. 1987. Saccharomyces cerevisiae genomic plasmid bank               1988. Autoregulation 2,u circle gene expression provides       based centromere-containing shuttle vector. Gene 60:237-             model maintenance stable plasmid copy levels. Cell
      243.                                                                      52:27-37.
53.   Rothstein, R. 1983. step gene disruption yeast. Methods      61.   Swanson, M. S., M. Carlson, F. Winston. 1990. SPT6,       Enzymol. 101:202-211.                                                     essential gene affects transcription Saccharomyces cere-
54.   Sanger, F., S. Nicklen,  R. Coulson. 1977. DNA sequenc-             visiae, encodes nuclear protein extremely acidic
      ing chain-terminating inhibitors. Proc. Natl. Acad. Sci.             amino terminus. Mol. Cell. Biol. 10:4935-4941.
      USA 74:5463-5467.                                                   62.   Swanson, M. S., J. N. Hirschhorn, S.  Brown, F. Winston.
55.   Sentenac,  1985. Eukaryotic RNA polymerases. Crit. Rev.                 Unpublished data.
      Biochem. 18:31-90.                                                  63.   Swanson, M. S., F. Winston. Unpublished data.
56.   Sherman, F., G. R. Fink, C. W. Lawrence. 1978. Methods       yeast genetics: laboratory manual, revised ed. Cold Spring        64.   Winston, F., D. T. Chaleff, B. Valent, G. R. Fink. 1984.
      Harbor Laboratory, Cold Spring Harbor, N.Y.                               Mutations affecting Ty-mediated expression HIS4 gene 57.   Sikorski, R. S., P. Heiter. 1989. shuttle vectors         Saccharomyces cerevisiae. Genetics 107:179-197.
      yeast host strains designed efficient manipulation       65.   Winston, F., C. Dollard, E.  Malone, J. Clare, J. G. Kapakos,
      DNA Saccharomyces cerevisiae. Ge